|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-8-6
|
|
pubmed:abstractText |
Lymphocytopenia is a prognostic factor in Hodgkin's disease. In diffuse large B-cell lymphoma (DLBCL), data are much less established, in spite of numerous reports on immune system-lymphoma interactions. This study addresses the prognostic value of blood lymphocyte subsets at diagnosis in DLBCL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BeneM-CMC,
pubmed-author:CasasnovasOO,
pubmed-author:DebardA-LAL,
pubmed-author:Delfau-LarueM-HMH,
pubmed-author:EmileJ-FJF,
pubmed-author:FarcetJ-PJP,
pubmed-author:FeugierPP,
pubmed-author:GisselbrechtCC,
pubmed-author:Groupe d'étude des lymphomes de l'adulte,
pubmed-author:HaiounCC,
pubmed-author:JaisJ-PJP,
pubmed-author:KuhleinEE,
pubmed-author:LabaletteMM,
pubmed-author:PlonquetAA,
pubmed-author:RabianCC,
pubmed-author:SallesGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1209-15
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17496307-Adult,
pubmed-meshheading:17496307-Antibodies, Monoclonal,
pubmed-meshheading:17496307-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17496307-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17496307-B-Lymphocytes,
pubmed-meshheading:17496307-Bleomycin,
pubmed-meshheading:17496307-CD4-Positive T-Lymphocytes,
pubmed-meshheading:17496307-CD8-Positive T-Lymphocytes,
pubmed-meshheading:17496307-Cell Count,
pubmed-meshheading:17496307-Cyclophosphamide,
pubmed-meshheading:17496307-Doxorubicin,
pubmed-meshheading:17496307-Etoposide,
pubmed-meshheading:17496307-Female,
pubmed-meshheading:17496307-Flow Cytometry,
pubmed-meshheading:17496307-Humans,
pubmed-meshheading:17496307-Immunophenotyping,
pubmed-meshheading:17496307-Kaplan-Meier Estimate,
pubmed-meshheading:17496307-Killer Cells, Natural,
pubmed-meshheading:17496307-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:17496307-Lymphopenia,
pubmed-meshheading:17496307-Male,
pubmed-meshheading:17496307-Middle Aged,
pubmed-meshheading:17496307-Monocytes,
pubmed-meshheading:17496307-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:17496307-Treatment Outcome,
pubmed-meshheading:17496307-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
|
|
pubmed:affiliation |
Service d'Immunologie Biologique, Institut National de la Santé et de la Recherche Médicale, U617, Créteil, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
